← SynDRA
REDAFAMDASTAT
SynDRA canonical compound SYN0026168 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | FAAH |
|---|
| Mechanism of action | FAAH inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- FAAH INHIBITOR
- Anandamide amidohydrolase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PDPK1
- PDGFRA
- PAK6
- PAK5
- PAK4
- PAK3
- PAK2
- PAK1
- OXSR1
- OPRM1
- OPRK1
- OPRD1
- OGG1
- NUAK2
- NUAK1
- NTRK3
- NTRK2
- NTRK1
- NTHL1
- NLK
- NIM1K
- NEK9
- NEK7
- NEK6
- NEK5
- NEK4
- PDGFRB
- PHKA2
- PRKACA
- PHKG1
- PRKAA1
- PNCK
- PLK4
- PLK3
- PLK2
- PLK1
- PKN2
- PKN1
- PKMYT1
Cross-references
Synonyms
- PF-04457845
- CPD 23
- PF-4457845
- PF04457845
- PF 04457845
- UNII-H4C81M8YYW
- H4C81M8YYW
- CHEMBL1651534
- C23H20F3N5O2
- N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide
- N-Pyridazin-3-yl-4-((3-(5-(trifluoromethyl)pyridin-2-yl)oxyphenyl)methylidene)piperidine-1-carboxamide
- 1-Piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-;1-Piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-
- RefChem:928916
- DTXCID2067030
- MFCD18782721
- redafamdastat [INN]
- compound 23 [PMID: 21666860]
- GTPL6694
- orb1302952
- SCHEMBL1010408
- SCHEMBL29390562
- SCHEMBL30178141
- SCHEMBL30321431
- BDBM762514
- EX-A2309
- BDBM50335377
- s2421
- AKOS027338651
- CS-0868
- EBC-420074
- SB17493
- NCGC00378983-01
- NCGC00378983-03
- AC-36022
- AS-74797
- DA-66617
- FP103118
- HY-14376
- NS00072877
Look up REDAFAMDASTAT in the interactive SynDRA portal →